Number of DNA Testing Kits Sold by Different Companies in 2025
The consumer DNA testing market in 2025 continued to evolve from a simple ancestry trend into a global business connected […]
Insight Companies
Regional Trends
Europe, Middle East and Africa Safety Lancet Market: Growing Focus on Safer Blood Testing
Across hospitals in Germany, diabetes clinics in Saudi Arabia, laboratories in the UK, and healthcare centers in South Africa, safety
Regional Trends
Europe, Middle East and Africa Lancet and Pen Needles Market with Company Insights 2026
Every morning across Europe, the Middle East, and Africa, millions of people begin their day with a finger prick or
Latest Articles
U.S. Telehealth Companies Ranked by Market Share (2024)
The U.S. telehealth market in 2024 is valued at approximately $35–45 billion in direct telemedicine services, while the broader virtual
Country Specific Trends
What Are the Top CRDMO Companies in the U.S.?
The U.S. contract research, development, and manufacturing organization (CRDMO) industry has become one of the most important pillars of the
Insight Companies
Which Companies Are Associated With Owning Some of the Best-Known Consumer Health Brands?
The global consumer health industry has become one of the most powerful sectors within healthcare, supported by increasing awareness about
Insight Segments
HR+/HER2- Breast Cancer CDK4/6 Inhibitor Market Share: Palbociclib in the United States (2020–2024)
The U.S. HR-positive, HER2-negative breast cancer treatment market has witnessed major competitive shifts between 2020 and 2024, especially in the
Regional Trends
APAC Hospitals Expected to Increase Medical Device Spending Despite Slower Outlook in Japan
The medical device outlook across the Asia-Pacific remains highly positive as hospitals continue increasing investments in diagnostic systems, imaging equipment,
Latest Articles
OECD Countries with Top 10 Mammography Machines Per 1,000,000
Breast cancer continues to be one of the most diagnosed cancers among women worldwide, and early screening remains one of
Latest Articles
Novartis’ Kisqali Hits USD 1.5 Billion Quarterly Sales as Pluvicto and Scemblix Drive Oncology Growth
Novartis is entering a new phase of growth powered by blockbuster cancer medicines, radioligand therapy innovation, and precision oncology expansion.